106.14
前日終値:
$106.21
開ける:
$106.18
24時間の取引高:
5.86M
Relative Volume:
0.80
時価総額:
$157.03B
収益:
$18.49B
当期純損益:
$2.51B
株価収益率:
63.18
EPS:
1.68
ネットキャッシュフロー:
$2.72B
1週間 パフォーマンス:
+2.41%
1か月 パフォーマンス:
+1.77%
6か月 パフォーマンス:
+4.12%
1年 パフォーマンス:
+42.93%
Boston Scientific Corp Stock (BSX) Company Profile
名前
Boston Scientific Corp
セクター
電話
508-683-4000
住所
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
BSX を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
BSX
Boston Scientific Corp
|
106.14 | 159.43B | 18.49B | 2.51B | 2.72B | 1.68 |
![]()
ABT
Abbott Laboratories
|
126.54 | 218.59B | 43.11B | 13.98B | 6.66B | 7.98 |
![]()
SYK
Stryker Corp
|
403.53 | 151.59B | 23.22B | 2.86B | 3.58B | 7.40 |
![]()
MDT
Medtronic Plc
|
92.94 | 118.29B | 33.54B | 4.66B | 5.19B | 3.62 |
![]()
EW
Edwards Lifesciences Corp
|
80.00 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-06-16 | 開始されました | Leerink Partners | Outperform |
2025-04-16 | アップグレード | Needham | Hold → Buy |
2025-01-10 | アップグレード | Deutsche Bank | Hold → Buy |
2024-10-18 | ダウングレード | Needham | Buy → Hold |
2024-05-30 | 開始されました | Goldman | Buy |
2024-02-01 | アップグレード | Mizuho | Neutral → Buy |
2023-07-19 | 開始されました | Robert W. Baird | Outperform |
2023-06-30 | 開始されました | CL King | Buy |
2023-05-30 | 再開されました | Morgan Stanley | Overweight |
2023-03-29 | 開始されました | UBS | Buy |
2022-12-22 | 開始されました | Mizuho | Neutral |
2022-12-20 | 再開されました | Citigroup | Buy |
2022-10-18 | 開始されました | Barclays | Overweight |
2022-10-12 | 開始されました | Jefferies | Buy |
2022-07-06 | 開始されました | Wolfe Research | Outperform |
2022-05-27 | アップグレード | Needham | Hold → Buy |
2022-04-13 | 再開されました | Truist | Buy |
2022-03-02 | 再開されました | BofA Securities | Buy |
2021-12-10 | 開始されました | RBC Capital Mkts | Outperform |
2021-05-26 | ダウングレード | Needham | Buy → Hold |
2021-05-25 | 開始されました | Barclays | Overweight |
2021-04-15 | 開始されました | Atlantic Equities | Overweight |
2020-09-17 | 開始されました | Truist | Buy |
2020-09-11 | 開始されました | Wolfe Research | Peer Perform |
2020-04-22 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
2020-04-01 | アップグレード | Goldman | Neutral → Buy |
2020-03-05 | 開始されました | Citigroup | Buy |
2020-02-13 | 開始されました | Goldman | Neutral |
2020-02-06 | 再開されました | BTIG Research | Buy |
2019-12-30 | 繰り返されました | Cowen | Outperform |
2019-12-19 | ダウングレード | Needham | Strong Buy → Buy |
2019-09-05 | 再開されました | JP Morgan | Overweight |
2019-09-03 | 再開されました | Barclays | Overweight |
2019-05-13 | アップグレード | Evercore ISI | In-line → Outperform |
2018-11-28 | 開始されました | UBS | Buy |
2018-10-16 | 開始されました | Barclays | Overweight |
2018-10-02 | 繰り返されました | Morgan Stanley | Overweight |
2018-09-07 | 繰り返されました | Needham | Strong Buy |
2018-09-04 | アップグレード | Jefferies | Hold → Buy |
2018-07-06 | 繰り返されました | Needham | Strong Buy |
2018-06-27 | 開始されました | Bernstein | Outperform |
2018-04-26 | 繰り返されました | Needham | Strong Buy |
すべてを表示
Boston Scientific Corp (BSX) 最新ニュース
Boston Scientific's (NYSE:BSX) investors will be pleased with their solid 173% return over the last five years - Yahoo.co
Boston Scientific (BSX) Target Price Raised by Raymond James | B - GuruFocus
Boston Scientific (BSX) Price Target Raised by Oppenheimer | BSX Stock News - GuruFocus
Is Boston Scientific Corporation stock overhyped or has real potentialSuperior stock growth - jammulinksnews.com
Boston Sci posts 117% U.S. PFA growth, halves tariff impact - BioWorld MedTech
Boston Scientific stock price target raised to $130 from $124 at Bernstein - Investing.com Canada
Boston Scientific (BSX) Price Target Increased by RBC Capital | - GuruFocus
BSX: Boston Scientific Sees Price Target Raised by Truist Securi - GuruFocus
Boston Scientific (BSX) Price Target Raised by Baird Analyst | B - GuruFocus
Boston Scientific Corporation (NYSE:BSX) Q2 2025 Earnings Call Transcript - Insider Monkey
Boston Scientific stock price target raised to $140 from $130 at Mizuho - Investing.com
Boston Scientific (BSX) Price Target Raised to $118 by Oppenheimer | BSX Stock News - GuruFocus
UBS Boosts Price Target for Boston Scientific (BSX) Amid Strong Performance | BSX Stock News - GuruFocus
Company News for Jul 24, 2025 - The Globe and Mail
Boston Scientific stock price target raised to $124 by Wells Fargo on PFA growth - Investing.com
Boston Scientific (BSX) Sees Price Target Boost from Barclays | - GuruFocus
Boston Scientific’s Strong Financial Performance and Positive Outlook Earns Buy Rating - TipRanks
Should You Buy or Sell Boston Scientific Stock Ahead of Its Upcoming Earnings? - Nasdaq
Why Boston Scientific (BSX) Stock Is Up Today - Yahoo Finance
Boston Scientific Beats on Q2 Earnings, Raises 2025 View, Stock Up - The Globe and Mail
Boston Scientific stock price target raised to $120 by BofA Securities - Investing.com
Boston Scientific (BSX) Price Target Increased by BofA Analyst | - GuruFocus
Boston Scientific Presses Its Advantage in Pulsed Field Ablation - Morningstar
Boston Scientific halves expected tariff hit - MedTech Dive
Boston Scientific Lifts Outlook On Cardiovascular Revenue Growth - Finimize
Boston Scientific lifts annual profit forecast, sees smaller tariff impact - Reuters
Boston Scientific lifts annual profit forecast, sees smaller tariff impact By Reuters - Investing.com
Boston Scientific Reports Higher Profit Margins In Q2, Lifts Guidance - Benzinga
Boston Scientific stock hits all-time high at 107.76 USD - Investing.com
Boston Scientific stock hits all-time high at 107.76 USD By Investing.com - Investing.com UK
Earnings call transcript: Boston Scientific Q2 2025 beats expectations, stock rises - Investing.com
Boston Scientific lifts annual profit view on steady heart devices demand - Yahoo.co
Boston Scientific: Q2 Earnings Snapshot - CTPost
Boston Scientific (BSX) Q2 Earnings and Revenues Surpass Estimates - Nasdaq
Boston Scientific increases full-year guidance after Q2 beats - MassDevice
Boston Scientific Q2 2025 Earnings Outperform Guidance with 22.8% Sales Growth 13.6% EPS Rise - AInvest
Boston Scientific Corp (BSX) Q2 2025 Earnings: EPS of $0.53 Beats Estimate, Revenue Surges to $5.061 Billion - GuruFocus
Boston Scientific Boosts FY25 OutlookUpdate - Nasdaq
Boston Scientific (BSX) Surpasses Q2 Earnings and Revenue Expectations - GuruFocus
Boston Scientific Q2 2025 slides: 22.8% sales growth fueled by Electrophysiology surge - Investing.com
Boston Scientific trumps top and bottom-line forecasts, issues upbeat 2025 guide - Investing.com
Boston Scientific earnings beat by $0.02, revenue topped estimates - Investing.com
Boston Scientific Q2 2025 Financial Results - TradingView
Boston Scientific announces results for second quarter 2025 - Financial Times
Is Boston Scientific Corporation a good long term investmentTriple-digit returns - jammulinksnews.com
Boston Scientific (BSX) Anticipates Robust Q2 Earnings Growth - GuruFocus
FDA expands Boston Sci’s Watchman label to post-ablation - BioWorld MedTech
Raymond James maintains Strong Buy on Boston Scientific stock - Investing.com
Boston Scientific Watchman wins FDA expansion for post-ablation patients - MassDevice
Boston Scientific stock set to beat Q2 estimates, says TD Cowen - Investing.com
Boston Scientific: Strong Growth Potential and Positive Outlook Justify Buy Rating - TipRanks
Boston Scientific Corp (BSX) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):